Peanuts and stress: does eating peanuts affect heart health markers in people under high stress
Official title: Effects of Peanut Consumption on Physiological and Psychosocial Stress, Circulating Immune Cell Status, Markers of Inflammation and Cardiovascular Disease Risk, and Gastrointestinal Health in High-Stress Individuals
Run by USDA, Western Human Nutrition Research Center · NCT07735221 · Data updated 2026-11-12
This study tests whether adding roasted peanuts to the diet can improve immune and cardiovascular risk markers in adults who report high chronic stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | USDA, Western Human Nutrition Research Center Federal |
| Locations | 1 site (Davis, California) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | August 2028 |
| Study ends | August 2028 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07735221 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with BMI 18.5–39.9 kg/m2 and a high perceived stress score who do not have major nut allergies or conflicting medications.
✕Probably not a fit
Individuals with preexisting severe nut allergies or who do not respond to dietary peanut exposure related to their baseline health status may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates whether daily consumption of roasted, salted peanuts with skins influences indicators of cardiovascular disease risk in adults experiencing high perceived stress. Nut consumption is the dietary exposure, with isocaloric foods used to help isolate effects on immune function, inflammation, and vascular health. Eligible participants are adults aged 18–65 with BMI 18.5–39.9 kg/m2 and a confirmed high stress level by the PSS-4. The study aims to understand if peanut intake can modulate stress-related physiological pathways, including SNS and HPA axis activity, and thereby impact CVD risk markers. No results are provided here; the trial protocol outlines procedures to monitor safety and collect relevant biomarkers over the intervention period.
Why it matters
Potential benefit: If successful, participants could experience improvements in cardiovascular risk markers associated with chronic stress.
How similar studies have gone: Previous nutrition studies suggest that certain nuts can favorably influence inflammation and cardiovascular markers, though results vary by context and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females * 18-65 years old * BMI ≥ 18.5 kg/m2 and ≤ 39.9 kg/ m2 * Recruitment will be based on Perceived Stress Scale - 4 (PSS-4) score Exclusion Criteria: * Less than 18 and over 65 years old * Pregnant or lactating women * Adults who rely on prescription medication that may influence study variables, apart from birth control * BMI \< 18.5 kg/m2 and \> 39.9 kg/m2 * Smokers who currently use tobacco- or marijuana-containing products including e-cigarettes, vape pens, pod mods, tanks, and electronic nicotine delivery devices (ENDS) * Habitual consumption of nuts, nut butters, nut powders, nut side dishes, nut bars or other nut products * Known food allergies (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, sesame, corn) due to samples not prepared in a hypoallergenic environment * Currently living in close contact with individuals who have an allergy to peanuts, in order to avoid exposing these individuals to an allergen * Self-reported history of difficulties with blood drawing procedures including prior fainting or dizziness, or veins assessed as not suitable for four separate venipunctures by licensed phlebotomist * Diagnosed active chronic diseases for which the individual is currently taking daily medication, including but not limited to: * Diabetes mellitus, cardiovascular disease, cancer, gastrointestinal disorders, kidney disease, liver disease, bleeding disorders, asthma, autoimmune disorders, hypertension, osteoporosis * Recent minor surgery (within 4 weeks) or major surgery (within 16 weeks) * Known gallbladder disease or history of cholecystectomy * History of gastrointestinal surgery, including gastric bypass surgery or resection * Diagnosis of irritable bowel syndrome * Recent antibiotic therapy (within 4 weeks) * Recent hospitalization (within 4 weeks) * Current participation in another research study * Has HIV/AIDS, hepatitis, or another disease that affects the immune system * Gives regular blood donations and is unwilling to stop during the study * Blood Pressure ≥ 140 mmHg systolic or 90 mmHg diastolic * Current diagnoses of an eating disorder (ex. anorexia, bulimia, etc.) * High - very high triglyceride levels: ≥ 300 mg/dL * Adults who are unable to consent, individuals who are not yet adults (infants, children and teenagers), pregnant women and prisoners will be excluded from participation in the study * Participants who are unwilling to collect and transport urine, stool and saliva samples * Abnormal hemoglobin and/or hematocrit levels * Abnormal liver function (defined as liver enzymes that are \>200% of upper limit (ALT upper limit is 43 U/L or Aspartate transaminase (AST) upper limit is 54 U/L) * Unwillingness to discontinue probiotic, prebiotic, fiber, or other supplements (except RDA-level vitamin and mineral supplements) during the study * Unwilling to consume study foods * Alcohol consumption \> 20 g/day
Where it's running
-
Western Human Nutrition Research Center
Davis, California, United States Recruiting
Study contacts
- Principal investigator: Ryan Snodgrass, PhD — United States Department of Agriculture - Western Human Nutrition Research Center
- Study coordinator: Ellen Bonnel, PhD
- Email: elbonnel@ucdavis.edu
- Phone: 530-752-4184
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital Health Education to Improve Heart Health Across Different Socioeconomic Groups (e-DUCASS Advance)
This study tests a 24-month digital health education program to see if it can improve cardiovascular health among people in Córdoba, Spain from varied socioeconomic backgrounds, by delivering weekly online content to families.
-
Omega-3 supplement to boost DHA and EPA levels in the blood
This 12-week study tests whether the Omega Active supplement raises blood DHA and EPA levels in healthy adults aged 18–65 who have omega-3 needs.
-
Immunomodulatory effects of Spirulina Blue Protein capsules in healthy adults
This study tests whether Spirulina Blue Protein capsules can modulate immune function in healthy adults over 12 weeks, compared with a placebo.
-
Beetroot Extract and Exercise for Health in Adults Aged 75+
This study tests whether beetroot extract, alone and with a multicomponent exercise program, can improve blood pressure, functional performance, and cognitive function in adults 75 and older.
-
Dyadic Multidimensional Sleep Health Promotion for Couples
A couples-focused program tests whether a multidimensional sleep health approach can improve sleep quality and blood pressure in both partners.
-
Self-affirmation and heart responses during grief
This trial will test whether a brief self-affirmation exercise helps adults grieving a recent loss have calmer heart and blood pressure responses during and after recalling their loss.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.